Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2005, Vol. 10 ›› Issue (1): 65-68.

Previous Articles     Next Articles

Effects of Ca2+ CaM-dependent calcineurin signaling pathway on cardiomyocytes hypertrophy of rats induced by neuropeptide Y

DONG Qi, CHEN Min-sheng1, HUANG Shao-hua2, LI Xiao-yun1, LI Ying-hui3, ZHANG Shu4, LIU Zhen-xiu3   

  1. Department of Physiology, 1Department of Cardiology, the Second Affiliated Hospital, 2Editory of Academic Journal, Guangzhou Medical College, Guangzhou 510260, Guangdong, China;
    3Institute of Spaceflight Medical engine, Beijng 100094;
    4Department of Spaceflight Physiology, the Forth Military Medical University, Xi'an 710054, Shannxi
  • Received:2004-11-09 Revised:2004-12-24 Online:2005-01-26 Published:2020-11-19

Abstract: AIM: To investigate the effects of Ca2+ CaM-dependent calcineurin (CaN) signaling pathway on cardiomyocytes hypertrophy of rat induced by neuropeptide Y (NPY).METHODS: Cardiomyocytes of neonatal Wistar rats were cultured with NPY of various concentrations (10, 100 nmol·L-1).Cyclosporine A (CsA) was used to inhibit the activity of CaN.The methods of 3H-Leu incorporation was used to assess protein synthesis rate in cardiomyocytes.Western-blot and histochemistry were used to measure CaN protein expression and CaN activity in cardiomyocytes.RESULTS: 3H-Leu incorporation of cardiomyocytes were increased significantly by 100 nmol·L-1NPY (P <0.05) and decreased by CsA.CaN activity and CaN-αprotein expression was elevated markedly in cardiomyocytes by 100 nmol·L-1NPY (P < 0.05).CONCLUSION: Neuropeptide Y activates Ca2+ CaM-dependent calcineurin signal pathway, and CsA can inhibit cardiomyocytes hypertrophy induced by NPY. It indicates that Ca2+ CaM-dependent calcineurin (CaN) signaling pathway plays an important role in cardiomyocytes hypertrophy of rats induced by NPY.

Key words: neuropeptide Y, calcineurin, cardiomyocytes hypertrophy

CLC Number: